Insulin resistance in Pima Indians appears to result from a post-receptor impairment of insulin signal transduction that affects only some responses to insulin. To identify the primary lesion responsible for insulin resistance, we investigated the influence of insulin on ribosomal protein S6 kinase activities in skeletal muscle ofinsulin-sensitive and insulin-resistant nondiabetic Pima Indians during a 2-h hyperinsulinemic, euglycemic clamp. In sensitive subjects, S6 kinase activity was transiently activated fivefold over basal activity by 45 min of insulin infusion. Although basal activities in the two groups were similar, the response to insulin was delayed and restricted to about threefold over basal in subjects resistant to insulin. Two major S6 kinase activities in extracts of human muscle were resolved by chromatography on Mono Q. Peak 1, which accounted for basal activity owes to an enzyme antigenically related to the 90-kD S6 kinase II, a member of the rsk gene family. The major insulin-stimulated S6 kinase eluted as peak 2 and is antigenically related to a 70-kD S6 kinase. Our results show that insulin resistance impairs signaling to the 70-kD S6 kinase. (J.
Introduction
Impaired response ofskeletal muscle to insulin may be an early expression of the genetic abnormality that causes non-insulindependent diabetes mellitus in Pima Indians (1) and in other populations (2) . Because insulin receptor cDNAs from insulin-resistant Pima Indians predict a normal protein structure (3, 4) and studies of insulin binding and stimulation of the receptor protein tyrosine kinase activity in vitro have not revealed abnormalities that could account for insulin resistance (5) , the condition in Pima Indians likely results from a post-receptor defect in the mechanism of insulin signal transduction. This defect limits the ability ofinsulin to suppress protein tyrosine phosphatase activity (6) and to activate glycogen synthase (7) , glycogen synthase phosphatase (8) , and type 1 protein phosphatase (9) in skeletal muscle. However, regulation ofcasein kinase II by insulin does not appear to be impaired in insulin-resistant Pima Indians ( 10) , which suggests that it contributes to insulin action either upstream from the defect or in a separate pathway of insulin action.
To map the primary defect in the insulin signal transduction pathway that limits insulin action in resistant subjects, we examined the influence of insulin on activities of serine/ threonine-specific protein kinases known to contribute to insulin signaling ( 1) , in skeletal muscle of insulin-sensitive and -resistant subjects in vivo. Here, we report our findings on activities of ribosomal protein S6 kinases.
Methods
Hyperinsulinemic euglycemic clamp and muscle biopsy. After giving written informed consent, volunteers were admitted to the clinical research ward and given physical examinations. After an overnight fast, routine blood chemical and hematological examinations were performed. All subjects had normal physical examinations, electrocardiograms, and blood tests, and none were taking medications. After a minimum of2 d on a standard diet, each underwent a 75-g oral glucose tolerance test and underwater weighing to estimate body composition. The characteristics of the subjects and results of oral glucose tolerance tests are presented in Table I . Hyperinsulinemic, euglycemic clamps at a maximally stimulating plasma insulin concentration and multiple biopsies of the vastus lateralis muscle were performed as described ( 10) Table II. Extracts ofmuscle. Muscle obtained by biopsy was frozen in liquid nitrogen within 15 s and stored at -70°C before it was processed as described (10) . Dried muscle powder was mixed with buffer comprising 80 mM beta-glycerophosphate, 20 mM EGTA, 15 mM MgCI2, pH 7.3, at a ratio of 0.25 ml of buffer/mg and disrupted at 4°C using a polytron. The homogenates were centrifuged at 100,000 g for 30 min at 4°C, and the supernatant fractions were retained and assayed for S6 kinase activity.
FPLC mono Q chromatography. 20 mg of dry muscle powder was homogenized with a polytron in 2.3 ml of buffer comprising 50 mM beta-glycerophosphate, pH 7.3, 1.5 mM EGTA, 1 mM DTT, and 0.1 mM Na3VO4 (buffer A). The homogenate was centrifuged at 100,000g for 30 min at 4°C, and the resultant supernate was injected onto a l-ml Mono Q column in a cold room at a flow rate of 1 ml/min. After washing the column with 5 ml ofbuffer A, a linear gradient of0-0.5 M NaCl in buffer A was started at a flow rate of 0.5 ml/min. The first seven fractions were of I ml vol and subsequent fractions were 0.2 ml. In a preliminary experiment, aO-l-M NaCl gradient was run. No additional S6 kinase activity was eluted with a salt concentration >0.5 M (data not shown).
S6 kinase assay. 40S ribosomal subunits were isolated from livers of rats that had been fasted overnight ( 13 (14) and heating in boiling water for 5 min. Proteins in the reaction mixture were resolved by SDS-PAGE on 12.5% polyacrylamide gels, which were then stained with Coomassie brilliant blue-R, destained, and dried. After autoradiography, the labeled S6 protein was cut from the gels and incorporated radioactivity was estimated by liquid scintillation spectrometry. Protein was assayed as described by Bradford (15) . Immunoblots. Proteins in individual fractions obtained from Mono Q chromatography were precipitated with 10% TCA in the presence of 200 MAg of carrier ovalbumin and collected by sedimentation at 15,000 g for 5 min. The pellets were solubilized by mixing with 75 Ml of 3x Laemmli sample buffer (14) for 1 h. Basic pH of the samples was maintained by adding 0.2 N NaOH. Pooled fractions ofS6 kinase were concentrated with centrifugal concentrators and proteins were denatured in Laemmli sample buffer. The samples were boiled for 5 min and proteins were resolved by SDS-PAGE on a 7.5% polyacrylamide gel and electrotransferred to nitrocellulose, which was then blocked as described (16 Erikson, Harvard University, Boston, MA) followed by I 25-protein A and autoradiography (16) .
Results
Infusion of insulin resulted in a rapid, transient increase in S6 kinase activity in extracts of muscle obtained from insulin-sensitive subjects (Fig. 1 ) . The majority ofthe activation occurred between 15 and 30 min ofinsulin infusion and reached a maximum of approximately fivefold over basal activity at 45 min before declining. Basal activities in insulin-sensitive and -resistant subjects were similar, but the response to insulin of S6 kinase activity in muscle of insulin-resistant subjects was restricted and delayed ( Fig. 1 ). Insulin increased activity in resistant subjects only about threefold and the maximum was not reached until 60 min. S6 kinase activity in the two groups appeared to decline toward basal levels at similar rates.
The lack ofa large increase in S6 kinase activity between 15 and 30 min of insulin infusion in muscle of insulin-resistant subjects was striking (Fig. 1) . To determine if this difference reflected impaired activation of a particular S6 kinase enzyme, S6 kinase activities in skeletal muscle were resolved by Mono Q chromatography (Fig. 2) . In muscle of both insulin-sensitive and insulin-resistant subjects, insulin-stimulated S6 kinase activity can be accounted for by two major activities, labeled peaks 1 and 2. The small shoulder to peak 1 (labeled IA) was observed in all separations. In both groups of subjects, S6 kinase(s) eluting as peaks 1 and IA account for basal activity; there is virtually no activity eluting as peak 2. At a time of maximal insulin stimulation, S6 kinase activities are increased in both insulin-sensitive and -resistant subjects, but the increases in the resistant subject are less.
To assess the contributions ofthe two major S6 kinase activities to total insulin-stimulated activity during the timecourse (Fig. 4 B) . The antibody to 70 kD S6 Figure 3 . Timecourse of activation of S6 kinases by insulin in human skeletal muscle. S6 kinase activities in extracts of muscle samples from an insulin-sensitive subject were resolved by Mono Q chromatography. Total S6 kinase activity in peaks 1 (o) and 2 (e) (see Fig.  2 kinase did not detect antigen in individual fractions of peak 2, perhaps owing to low abundance ofthe protein or to low titer of the antibody. However, a band with a relative molecular mass equal to 73 kD was detected in a concentrated pool offractions comprising peak 2 (Fig. 4 B) . Anti-rsk antibody gave no signal in either individual peak 2 fractions or in the pooled peak 2 (data not shown). Based on these results, it appears that S6 kinase activity in peaks 1 and 1A owes to a rsk-related enzyme(s) and that peak 2 activity owes to an enzyme related to the 70-kD S6 kinase.
Discussion
The Pima Indians have the highest known prevalence of noninsulin-dependent diabetes mellitus, a disease that may be inherited in this population as a single autosomal gene ( 1). Longitudinal studies have shown that the development ofimpaired glucose tolerance, which is characterized by a reduced capacity of skeletal muscle to respond to insulin, precedes and predicts development of non-insulin-dependent diabetes mellitus (26, 27 (6) , glycogen synthase (7), glycogen synthase phosphatase (8) , and type 1 protein phosphatase (9) , and to alter mRNA levels of certain genes, but not others (Thompson, B., and J. Sommercorn, unpublished observations). These differential effects of insulin resistance on elements of insulin action are consistent with evidence of at least two pathways of insulin signal transduction (31) (32) (33) (34) and suggest that the primary cause ofinsulin resistance in Pima Indians may affect only one ofthe pathways. Studies of insulin action in a population with an inherent defect in one aspect ofinsulin signaling allows segregation of insulin responses into different pathways. This should facilitate application ofadvances in understanding ofthe mechanism of insulin action to our objective of determining the primary cause of insulin resistance in the Pima Indians. Our findings that insulin resistance impairs both activation of 70-kD S6 kinase, which is thought to contribute primarily to regulation of protein synthesis, and signaling to the nucleus (see above) suggest that although insulin resistance has been defined in terms of glucose metabolism, it may be more accurate to think of it as an insulin signal deficiency that impairs many aspects ofinsulin function. The pathologic consequences of insulin resistance may result as much or more from impaired regulation of gene expression or protein synthesis as from abnormal glucose homeostasis.
Among the larger effects of insulin on protein kinases is its stimulation of activity toward ribosomal protein S6, an effect that has been observed in a wide variety of cells and tissues. This large stimulation of S6 kinase activity was also detected in skeletal muscle of insulin-sensitive humans, but the response was impaired in those resistant to the hormone (Fig. 1) . In this study, insulin-resistant subjects were significantly older and fatter than insulin-sensitive subjects (Table I) . Therefore, we cannot rule out the possibility that abnormal regulation of S6 kinase activity is a function ofage or obesity rather than insulin sensitivity. These alternative explanations are unlikely however, since others have shown that insulin action is not correlated with degree ofobesity (35) (36) (37) , and that glucose tolerance and insulin sensitivity are not correlated with age (38, 39) in the ranges reflective of the subjects in our study.
Kinases related to both the rsk gene product and a 70-kD S6 kinase are expressed in human skeletal muscle. Our studies show that the major insulin-stimulated S6 kinase in human muscle is antigenically related to the 70-kD enzyme, consistent with the fact that S6 kinase purified from cells or tissues exposed to insulin or growth-promoting stimuli has a relative molecular mass of -70 kD (22) (23) (24) (25) . Our results also show that insulin resistance restricts the activation of the 70-kD S6 kinase by insulin. Thus, investigation of the influence of insulin resistance on the ability of insulin to regulate kinases that in turn phosphorylate and activate the 70-kD S6 kinase (40, 41) may lead to the primary defect in insulin signal transduction that results in insulin resistance in the Pima Indians.
Lavoinne et al. reported purification of an insulin-stimulated protein kinase that is similar to S6 kinase II (a rsk kinase) both enzymatically and immunologically (42) . Insulin-stimulated protein kinase appears to mediate phosphorylation of site 1 in the G-component of glycogen-bound type 1 phosphatase (PP1-G) that is associated with increased activity of PP1-G in response to insulin (43) . Thus, the rsk kinase(s) may have a broader role in insulin action than phosphorylation of S6 protein. Because ribosomal protein S6 is a poor substrate for rsk kinase, our results do not resolve the question of whether insulin resistance affects the activation of rsk kinase by insulin. Use of an alternative substrate, S6 peptide (RRLSSLRA), which is a better substrate for rsk than for 70-kD S6 kinase, did not clarify this point, since we found evidence of at least four insulin-stimulated S6 peptide kinase activities in extracts of human skeletal muscle (data not shown). Attempts to specifically assay rsk by immunoprecipitation were unsuccessful. This question concerning rsk activation in insulin resistance will be important to resolve, since abnormal activation of rsk kinase may explain impaired insulin activation of type 1 phosphatase in insulin-resistant Pima Indians (9) .
